Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from KITE

3 Stocks with Tremendous Growth Potential in 2023

Given the pace and intensity of the Fed’s monetary tightening, there’s a strong likelihood that the U.S. will enter a recession in 2023. However, amid a strong job market and resilient consumer spending, the possibility of a soft landing still stands. Given this backdrop, quality stocks Gilead Sciences (GILD), Coca-Cola…

StockNews.com

2 Dividend Stocks That Could Pay You for the Rest of Your Life

As the market remains volatile due to ongoing concerns about elevated inflation, prolonged rate hikes, and an impending recession, fundamentally strong dividend stocks Bristol-Myers Squibb (BMY) Gilead Sciences (GILD) might be ideal buys to ensure a stable income stream. Moreover, these stocks could be great long-term investments. Read more.

StockNews.com

1 Resilient Growth Stock to Buy Now and Hold Forever

Biopharmaceutical giant Gilead Sciences’ (GILD) shares have risen nearly 30% over the past year despite lingering macroeconomic challenges. Moreover, the company delivered solid growth last year and is expected to maintain its business momentum in 2023 and beyond, driven by its diversified medicines portfolio. Hence, investors could consider buying and…

StockNews.com

From analysis to the latest developments in health,
read the most diverse news in one place.

3 High-Value Stocks to Buy and Hold for a Lifetime

Despite showing signs of cooling, inflation is still well above the Fed’s 2% target. Moreover, January’s strong jobs report may encourage the Fed to raise interest rates even further, keeping the stock market highly volatile in the near term. Amid an uncertain macro environment, it could be wise to buy…

StockNews.com

KITE equips 19 lakh school children to handle fake news

Thiruvananthapuuram

The Hindu

3 Biotech Stocks to Buy for Q4 and 1 to Avoid

Favorable federal investments are anticipated to fuel further expansion in the biotech industry. Given the sector’s good prospects, quality biotech stocks Amgen (AMGN), Gilead Sciences (GILD), and Biogen (BIIB) could be ideal buys. However, fundamentally weak stock Intra-Cellular Therapies (ITCI) might be best avoided. Read on….

StockNews.com

1 Stock Under $65 That You Shouldn't Ignore

Leading biopharmaceutical company Gilead Sciences (GILD) reported impressive sales in the last quarter and raised its full-year 2022 guidance. Furthermore, the company’s strategic acquisitions, drug approvals, and research breakthroughs should drive its growth in the coming quarters. Given GILD’s discounted valuation, we think it could be wise to buy this…

StockNews.com

Read news from The Economist, FT, and more,
with one subscription

Software Freedom Day: KITE to hold training sessions in Kerala districts on Sunday

Minister for General Education V. Sivankutty will inaugurate the training which is being organised jointly with the Democratic Alliance for Knowledge Freedom

The Hindu

KITE, BSNL tie up for 100 Mbps broadband for school

12.5 times faster connectivity to be available in schools

The Hindu

Recap Of Friday's Biotech Catalysts - End Of The Day Summary

Bristol Myers Squibb (NYSE:BMY) received European Medicines Agency (EMA) Positive CHMP Opinion recommending approval for Opdualag (nivolumab and relatlimab) for treatment of patients with Unresectable or Metastatic Melanoma based on results from the Phase 2/3 RELATIVITY-047 trial. Bristol Myers shares traded in a range of $72.48 to $73.61 on a…

Benzinga

KITE gets CM’s Award for Innovations in Public Policy

Thiruvananthapuram

The Hindu

2 Oversold Stocks Investors Will Want to Buy Before They Blast Off

The stock market sell-offs triggered by macroeconomic and geopolitical issues since the beginning of the year have driven many quality stocks into the oversold territory. So, it could be wise to invest in oversold stocks Gilead Sciences (GILD) and Comcast (CMCSA), which have solid rebound potential. Let’s discuss….

StockNews.com

9,000 robotics kits for 2,000 high schools: Sivankutty

Thiruvananthapuram

The Hindu

Residential camps for Little KITEs students in Kerala from Saturday

Thiruvananthapuram

The Hindu

Get all your
news in one place.

100’s of premium titles.
One news app.

The Hindu

SchoolWiki plays a huge role in strengthening Malayalam in digital media: Kerala Speaker

Awards, citations presented to winners

The Hindu

School Wiki awards announced

MM UPS, Maakkootam, wins first prize of ₹1.5 lakh

The Hindu

Digital profile of all students to be readied: Sivankutty

Thiruvananthapuram

StockNews.com

3 Low-Beta Stocks to Buy to Combat a Jittery Market

The Fed’s aggressive interest rate increases to tame multi-decade high inflation, and an anticipated economic slowdown, have exacerbated market volatility of late. To protect against the market uncertainties, we think investors should consider investing in low-beta stocks Merck (MRK), Gilead Sciences (GILD), and AmerisourceBergen (ABC). Let’s discuss why.

Get all your
news in one place.

100’s of premium titles.
One news app.

StockNews.com

3 Healthcare Stocks That Pay Dominant Dividends

Despite heightened market volatility, the healthcare industry is expected to grow significantly in 2022 amid surging chronic diseases worldwide, an aging population, increasing healthcare expenditure, and numerous medical advancements. So, we think it could be wise to invest in fundamentally sound healthcare stocks Gilead (GILD), Takeda (TAK), and GlaxoSmithKline (GSK).…

The Hindu

Cyber safety training for 25,000 mothers in Thiruvananthapuram

Training led by Little KITEs IT clubs members begins today

The Hindu

Cyber safety training for three lakh female parents

Training through Little KITEs IT clubs in high schools from Saturday

StockNews.com

Looking for Value Stocks to Add to Your Portfolio? Here are 5 For Your List

Heightened inflationary pressure, deepening supply chain disruptions, and the possibility of aggressive interest rate hikes later this year have fostered a volatile stock market. Because these factors are not expected to abate anytime soon, we think investors looking to generate solid long-term returns could consider betting on the stocks of…

Chicago Tribune

Creeping interest rates are cause for pause, readjustment of expectations when it comes to home buying

The housing market has had a lot to contend with recently: The COVID-19 pandemic. Property tax increases. Inflation. Rising costs of construction material. A shortage of housing inventory.

The Hindu

Distribution of laptops under Vidyakiranam begins

Thiruvananthapuram

The Hindu

CM releases KITE’s FOSS-based operating system suite

It can be used as a complete computing platform by students and teachers

1 2 3

People

Jerome Powell

2,717 stories

Dipanjan BanchurSince

722 stories

Kritika SarmahHer

701 stories

Mangeet Kaur BounsMangeet

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.